Will Champions Oncology (NASDAQ:CSBR) Spend Its Cash Wisely?

Yahoo FinanceApr 18 03:45

Champions Oncology Cut to Hold From Buy by Craig-Hallum

Champions Oncology Cut to Hold From Buy by Craig-Hallum

Dow JonesMar 13 20:31

Craig-Hallum Downgrades Champions Oncology to Hold

Craig-Hallum analyst Matt Hewitt downgrades Champions Oncology from Buy to Hold.

Analyst UpgradesMar 13 20:21

Champions Oncology Analyst Ratings

Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating 03/13/2024 — Craig-Hallum Downgrades Buy → Hold 09/22/2023 32.74% Roth MKM $9 → $7.5 Maintains Buy 03/15/

BenzingaMar 13 20:19

Earnings Call Summary | Champions Oncology(CSBR.US) Q3 2024 Earnings Conference

The following is a summary of the Champions Oncology, Inc. (CSBR) Q3 2024 Earnings Call Transcript:Financial Performance:Champions Oncology reported Q3 revenue of $12 million, a 6% decline compared to

Futu NewsMar 13 08:00 · Conference Call

Champions Oncology Non-GAAP EPS of -$0.16, Revenue of $12M

Seeking AlphaMar 13 05:18